Vimarsana
Biggest News Aggregation in the World

Page 5 - First Half Year News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Half Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Half Year Today - Breaking & Trending Today

Eurofins Scientific: Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022 - Vimarsana News

Eurofins Scientific: Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022

Published: July 27, 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): Revenues increased to a record level of €3,412m in H1 2022, up 4.3% vs. H1 2021, driven by good growth of Eurofins' Core Business (excluding

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomCzech RepublicSan DiegoCastellon De La PlanaHo Chi Minh CityH ChíinhRepublic OfStanford UniversityAr RiyaSaudi ArabiaNew South WalesKingdom Of Saudi ArabiaInpac MedizintechnikEurofins Viracor BiopharmaMedizintechnik InpacGilles MartinEurofins ViracorEurofin BiopharmaEurofins TechnologieEurofins IpromaMedische MicrobiologieMaterial SciencesFitch RatingsInfrastructure Programme
DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 - Vimarsana News

DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

Published: July 12, 2022

DGAP-News: Heidelberg Pharma AG / Key word(s): Half Year Report Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 20...

Source: businessinsider.com
Related Topics:
United StatesHong KongTel AvivSri LankaUnited KingdomSouth KoreaSouth AustraliaRepublic OfRepublic Of ChinaTaiwan GeneralMacau GeneralSylvia WimmerJan SchmidtHeidelberg PharmaHeidelberg Pharma GroupRedhill Biopharma LtdHuadong Medicine Co LtdMc ServicesInternational Financial Reporting StandardsTelix PharmaceuticalsFrankfurt Stock ExchangeMinistry Of Economic AffairsFinancial Supervisory Authority BafinGmbh CoAmerican Association For Cancer Research
Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 - Vimarsana News

Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

Published: July 12, 2022

12.07.2022 Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

Source: dgap.de
Related Topics:
United StatesHong KongTel AvivSri LankaUnited KingdomSouth KoreaSouth AustraliaRepublic OfRepublic Of ChinaTaiwan GeneralMacau GeneralSylvia WimmerJan SchmidtHeidelberg PharmaHeidelberg Pharma GroupRedhill Biopharma LtdHuadong Medicine Co LtdMc ServicesInternational Financial Reporting StandardsTelix PharmaceuticalsFrankfurt Stock ExchangeMinistry Of Economic AffairsFinancial Supervisory Authority BafinGmbh CoAmerican Association For Cancer Research
Stocks Slide On Renewed Recession Fears; Worst H1 (First Half-Year) Ever - Vimarsana News

Stocks Slide On Renewed Recession Fears; Worst H1 (First Half-Year) Ever

Published: June 30, 2022

Stocks sank on Thursday to extend what is the worst first half of the year for global share prices on record

Source: ndtv.com
Related Topics:
United KingdomJerome PowellSteve EnglanderEuropean Central BankMarket CommitteeFederal ReserveStocks Slide On Renewed Recession FearsFirst Half YearEquity IndexFederal Open Market CommitteeStandard CharteredGlobal StocksWorld Stocks FallGlobal Financial Markets
Investegate |Clariant International Ltd Announcements | Clariant International Ltd: Clariant delays publication of Fourth Quarter / Full Year 2021 results - Vimarsana News

Investegate |Clariant International Ltd Announcements | Clariant International Ltd: Clariant delays publication of Fourth Quarter / Full Year 2021 results

Published: February 14, 2022

Investegate announcements from Clariant International Ltd, Clariant delays publication of Fourth Quarter / Full Year 2021 results

Source: investegate.co.uk
Related Topics:
Switzerland GeneralMaria IvekAndreas SchwarzwJochen DubielAlexander KambOanne MaierDunn CrutcherConrad KeijzerEllese GolderWhile The CompanyFourth QuarterFull YearChief Executive OfficerIntegrated ReportAnnual General MeetingChief ExecutiveFirst Half YearBusiness AreasCare ChemicalsInvestegate AnnouncementsInvestegate Company AnnouncementsClariant International LtdLobenewswire And Globenewswire